The Pharmacogenomics Journal - Table of Contents alert Volume 15 Issue 1

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 15, Issue 1 (February 2015) In this issue EELS Paper Review Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe   EELS Paper Top Management and return of incidental genomic findings in clinical trials C Ayuso, J M Millan and R Dal-Re Pharmacogenomics J 2015 15: 1-5; advance online publication, October 28, 2014; 10.1038/tpj.2014.62 Abstract | Full Text Review Top An evaluation of regulatory and commercial barriers to stratified medicine development and adoption N A Meadows, A Morrison, D A Brindley, A Schuh and R W Barker Pharmacogenomics J 2015 15: 6-12; advance online publication, October 7, 2014; 10.1038/tpj.2014.51 Abstract | Full Text Original Articles Top Opinions, hopes and concerns regarding pharmacogenomics: a comparison of healthy individuals, heart failure patients and heart transplant recipients K Lachance, S Korol, E O'Meara, A Ducharme, N Racine, M Liszkowski, J L Rouleau, G B Pelletier, M Carrier, M White and S de Denus Pharmacogenomics J 2015 15: 13-19; advance online publication, July 1, 2014; 10.1038/tpj.2014.29 Abstract | Full Text Clinical outcomes associated with proton pump inhibitor use among clopidogrel-treated patients within CYP2C19 genotype groups following acute myocardial infarction J P Depta, P A Lenzini, D E Lanfear, T Y Wang, J A Spertus, R G Bach and S Cresci Pharmacogenomics J 2015 15: 20-25; advance online publication, July 8, 2014; 10.1038/tpj.2014.28 Abstract | Full Text Functional characterization of 21 CYP2C19 allelic variants for clopidogrel 2-oxidation M Takahashi, T Saito, M Ito, C Tsukada, Y Katono, H Hosono, M Maekawa, M Shimada, N Mano, A Oda, N Hirasawa and M Hiratsuka Pharmacogenomics J 2015 15: 26-32; advance online publication, July 8, 2014; 10.1038/tpj.2014.30 Abstract | Full Text Impact of GATA4 variants on stable warfarin doses in patients with prosthetic heart valves E Jeong, K E Lee, H Jeong, B C Chang and H S Gwak Pharmacogenomics J 2015 15: 33-37; advance online publication, July 15, 2014; 10.1038/tpj.2014.36 Abstract | Full Text Effect of CYP3A5*3 on kidney transplant recipients treated with tacrolimus: a systematic review and meta-analysis of observational studies L Rojas, I Neumann, M José Herrero, V Bosó, J Reig, J Luis Poveda, J Megías, S Bea and S F Aliño Pharmacogenomics J 2015 15: 38-48; advance online publication, September 9, 2014; 10.1038/tpj.2014.38 Abstract | Full Text Therapeutic implications of novel mutations of the RFX6 gene associated with early-onset diabetes R Artuso, A Provenzano, B Mazzinghi, L Giunti, V Palazzo, E Andreucci, A Blasetti, R M Chiuri, F E Gianiorio, P Mandich, M Monami, E Mannucci and S Giglio Pharmacogenomics J 2015 15: 49-54; advance online publication, July 22, 2014; 10.1038/tpj.2014.37 Abstract | Full Text Genetic variation at glucose and insulin trait loci and response to glucose–insulin–potassium (GIK) therapy: the IMMEDIATE trial K L Ellis, Y Zhou, J R Beshansky, E Ainehsazan, Y Yang, H P Selker, G S Huggins, L A Cupples and I Peter Pharmacogenomics J 2015 15: 55-62; advance online publication, August 19, 2014; 10.1038/tpj.2014.41 Abstract | Full Text Identification of SNPs associated with response of breast cancer patients to neoadjuvant chemotherapy in the EORTC-10994 randomized phase III trial V Le Morvan, S Litière, A Laroche-Clary, S Ait-ouferoukh, R Bellott, C Messina, D Cameron, H Bonnefoi and J Robert Pharmacogenomics J 2015 15: 63-68; advance online publication, June 24, 2014; 10.1038/tpj.2014.24 Abstract | Full Text Genes involved in pericyte-driven tumor maturation predict treatment benefit of first-line FOLFIRI plus bevacizumab in patients with metastatic colorectal cancer N B Volz, S Stintzing, W Zhang, D Yang, Y Ning, T Wakatsuki, R E El-Khoueiry, J E Li, A Kardosh, F Loupakis, C Cremolini, A Falcone, S J Scherer and H-J Lenz Pharmacogenomics J 2015 15: 69-76; advance online publication, July 29, 2014; 10.1038/tpj.2014.40 Abstract | Full Text EGFR ligands and DNA repair genes: genomic predictors of complete response after capecitabine-based chemoradiotherapy in locally advanced rectal cancer A Sebio, J Salazar, D Páez, A Berenguer-Llergo, E del Río, M Tobeña, M Martín-Richard, I Sullivan, E Targarona, J Balart, M Baiget and A Barnadas Pharmacogenomics J 2015 15: 77-83; advance online publication, July 15, 2014; 10.1038/tpj.2014.33 Abstract | Full Text Tamoxifen metabolism predicts drug concentrations and outcome in premenopausal patients with early breast cancer OPEN P Saladores, T Mürdter, D Eccles, B Chowbay, N K Zgheib, S Winter, B Ganchev, B Eccles, S Gerty, A Tfayli, J S L Lim, Y S Yap, R C H Ng, N S Wong, R Dent, M Z Habbal, E Schaeffeler, M Eichelbaum, W Schroth, M Schwab and H Brauch Pharmacogenomics J 2015 15: 84-94; advance online publication, August 5, 2014; 10.1038/tpj.2014.34 Abstract | Full Text Interaction between the Val158Met catechol-O-methyltransferase gene variant and second-generation antipsychotic treatment on blood pressure in children A T Cote, C Panagiotopoulos and A M Devlin Pharmacogenomics J 2015 15: 95-100; advance online publication, July 22, 2014; 10.1038/tpj.2014.35 Abstract | Full Text Clinical and pharmacogenomic implications of genetic variation in a Southern Ethiopian population F Tekola-Ayele, A Adeyemo, A Aseffa, E Hailu, C Finan, G Davey, C N Rotimi and M J Newport Pharmacogenomics J 2015 15: 101-108; advance online publication, July 29, 2014; 10.1038/tpj.2014.39 Abstract | Full Text   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to The Pharmacogenomics Journal. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.